SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 64 filers reported holding SCPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -36.2% | 5,122 | -11.0% | 0.00% | – |
| Q2 2023 | $58 | -91.3% | 5,756 | -92.2% | 0.00% | – |
| Q1 2023 | $666 | -86.7% | 73,448 | +8923.1% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 814 | +5.7% | 0.00% | – |
| Q2 2021 | $5,000 | -87.2% | 770 | -86.8% | 0.00% | – |
| Q1 2021 | $39,000 | +225.0% | 5,849 | +159.0% | 0.00% | – |
| Q4 2020 | $12,000 | -50.0% | 2,258 | -27.7% | 0.00% | – |
| Q3 2020 | $24,000 | +9.1% | 3,123 | +4.6% | 0.00% | – |
| Q2 2020 | $22,000 | +2100.0% | 2,985 | +2002.1% | 0.00% | – |
| Q3 2019 | $1,000 | – | 142 | +14100.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2019 | $6,000 | +500.0% | 2,087 | +959.4% | 0.00% | – |
| Q4 2018 | $1,000 | -93.8% | 197 | -92.8% | 0.00% | – |
| Q3 2018 | $16,000 | +433.3% | 2,718 | +278.6% | 0.00% | – |
| Q2 2018 | $3,000 | -84.2% | 718 | -52.9% | 0.00% | – |
| Q1 2018 | $19,000 | – | 1,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,051,805 | $20,907,893 | 8.53% |
| 5AM Venture Management, LLC | 1,200,647 | $12,234,593 | 3.05% |
| Worth Venture Partners, LLC | 512,337 | $5,220,714 | 2.84% |
| COWEN AND COMPANY, LLC | 1,837,918 | $18,728,384 | 1.55% |
| Orbimed Advisors | 5,559,528 | $56,651,590 | 1.03% |
| RTW INVESTMENTS, LP | 3,297,843 | $33,605,020 | 0.64% |
| EAM Investors, LLC | 265,528 | $2,705,730 | 0.50% |
| Rubric Capital Management LP | 811,517 | $8,269,358 | 0.35% |
| Ikarian Capital, LLC | 150,000 | $1,528,500 | 0.24% |
| Leucadia National | 831,000 | $8,467,890 | 0.08% |